Although gene expression-based clustering was able to validate the IRX/HOXA axis as a substructure of KMT2A-r infant ALL, in order to reveal more refined disease subgroups, we further analyzed the same 61 infant leukemia samples with DNA methylation array. This evidence concerns the gene KMT2A and leukemia.